Categories: Automobile

NYSE Content Advisory: Pre-Market Update + BETA Technologies Raises Over $1 Billion in IPO

NEW YORK, Nov. 4, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on November 4th

- Advertisement -
  • Equities are pulling back early Tuesday after a run fueled by AI stocks. The S&P 500 added 0.2% Monday on the back of a 4% rally in shares of Amazon. The company inked a deal with OpenAI that sent it to a record close.
  • At a Summit in Hong Kong, Morgan Stanley’s Ted Pick and Goldman Sachs’ David Solomon warned of a double-digit pop after the S&P 500 surged more than 35% from its April lows.
  • Beta Technologies is set to debut on the NYSE today after pricing an upsized IPO at $34 each. The electric aircraft developed raised more than $1 billion by offering nearly 30 million shares. It will trade under the ticker symbol BETA.


Opening Bell


Beta Technologies (NYSE: BETA) celebrates its initial public offering

- Advertisement -


Closing Bell


Capital Group celebrates the 3-year anniversary of the launch of CGMS, CGMU and CGSD and the listing of its three newest ETFs – CGGG, CGVV and CGHY.

- Advertisement -


Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2813192/NYSE_Market_Update_November_4.mp4 
Logo – https://mma.prnewswire.com/media/2581322/5600792/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–beta-technologies-raises-over-1-billion-in-ipo-302604121.html

- Advertisement -
PRNW Agency

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

4 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

1 week ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago